Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany

Drug budget and prescription control measures are implemented regionally in Germany, meaning that the uptake of pharmaceuticals, including biosimilars, can vary by region. We examine regional market dynamics of tumor necrosis factor alpha (TNFα) inhibitor originators and biosimilars in Germany and s...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Evelien Moorkens, Teresa Barcina Lacosta, Arnold G. Vulto, Martin Schulz, Gabriele Gradl, Salka Enners, Gisbert Selke, Isabelle Huys, Steven Simoens
Format: Artigo
Jezik:Inglês
Izdano: MDPI AG 2020-10-01
Serija:Pharmaceuticals
Teme:
infliximab
etanercept
TNFα inhibitors
biologics
biosimilars
Germany
Online pristup:https://www.mdpi.com/1424-8247/13/10/324
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items